Reference is made to Aker BioMarine ASA's (the "Company") stock exchange announcement earlier today regarding the offer of new shares to employees in the Company and its Norwegian subsidiaries (the "Employee Share Purchase Program") and the board of directors' resolution to increase the share capital of the Company. 

The following primary insiders of the Company have applied for, been allocated and subscribed new shares in the Company at the offer price of NOK 54.56 per share in the Employee Share Purchase Program.

-	Matts Johansen, CEO, has subscribed for 879 new shares in the Company for a total subscription amount of NOK 47 958. Following the subscription, Johansen controls 1,095,837 shares in the Company.

-	Katrine Klaveness, CFO, has subscribed for 879 new shares in the Company for a total subscription amount of NOK 47 958. Following the subscription, Klaveness controls 6,623 shares in the Company.

-	Simon Seward, CEO Human Ingredients, has subscribed for 879 new shares in the Company for a total subscription amount of NOK 47 958. Following the subscription, Seward controls 3,783 shares in the Company.

-	Tone Lorentzen, COO Human Ingredients, has subscribed for 879 new shares in the Company for a total subscription amount of NOK 47 958. Following the subscription, Lorentzen controls 8,283 shares in the Company.

-	Trond Atle Smedsrud, CEO Emerging Business, has subscribed for 879 new shares in the Company for a total subscription amount of NOK 47 958. Following the subscription, Smedsrud controls 11,289 shares in the Company.

-	Anniken Færgestad, VP Finance, has subscribed for 879 new shares in the Company for a total subscription amount of NOK 47 958. Following the subscription, Færgestad controls 2,489 shares in the Company.

-	Lars Jacobsen, General Counsel, has subscribed for 879 new shares in the Company for a total subscription amount of NOK 47 958. Following the subscription, Jacobsen controls 3,473 shares in the Company.

-	Kristin Holmgren, Board Director, has subscribed for 879 shares in the Company for a total subscription amount of NOK 47 958. Following the subscription, Holmgren controls 4,346 shares in the Company.

Attached to this announcement is supplementary information regarding primary insiders’ share subscriptions.

For further information, please contact 
Christopher Robin Vinter, VP Strategic Finance & IR 
Mobile: +47 911 60 820 
Email: Christopher.vinter@akerbiomarine.com

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act.

About Aker BioMarine:
Aker BioMarine is a leading human health and nutrition innovator that develops krill-derived products for consumer health and nutrition. Krill is a natural, powerful, and health-promoting source of nutrients from the pristine waters of Antarctica, and Aker BioMarine has a unique position in its industry. The ingredient portfolio consists of Superba Krill Oil, Lysoveta, FloraMarine, and PL+, as well as the consumer brand, Kori Krill. The innovative approach also extends into the spin-offs AION (reduce and recycle plastic waste across industries) and Understory (a protein brand). Aker BioMarine is listed on the Oslo Stock Exchange (AKBM). More information is available at www.akerbiomarine.com.

